Search published articles


Showing 2 results for Disk Diffusion Antimicrobial Tests

Hesam Alizade , Fatemeh Fallah , Reza Ghanbarpour , Hosein Goudarzi , Hamid Sharifi , Mohammad Reza Aflatoonian ,
Volume 10, Issue 2 (3-2016)
Abstract

ABSTRACT

        Background and Objective: One of the main tasks of clinical microbiology laboratories is to determine antibiotic resistance profiles in common pathogens and ensure the selection of effective antibiotics for certain infections. The aim of this study was to compare the methods of disk diffusion, broth microdilution and modified Hodge test in Escherichia coli isolates from urinary tract infection and diarrhea for susceptibility testing against beta-lactam antibiotics in Kerman, Iran.

        Methods: In this study, 432 E. coli isolates were collected from diarrhea (216 isolates) and urinary tract infection samples (216 isolates). The antibiotic susceptibility testing methods of disk diffusion, broth microdilution and modified Hodge test were performed according to the Clinical and Laboratory Standards Institute guidelines.

      Results: The findings of disk diffusion method showed that resistance to cefotaxime, ceftazidime, aztreonam, cefepime and imipenem was 51.15%, 30.55%, 24.30%, 15.27% and 1.85%, respectively. In the disk diffusion test, 51.15% of the isolates were resistant to at least one antibiotic, all of which were later evaluated by the broth microdilution method. Moreover, 52.94%, 17.19%, 13.12% and 0.90% of the isolates were resistant to cefotaxime, ceftazidime, cefepime and imipenem, respectively. All of the isolates were evaluated for the production of carbapenemase enzyme by the modified Hodge test and none of the isolates were found as positive.

       Conclusion: This study shows that performing carbapenem tests is very challenging, and laboratories are recommended to use secondary and independent antibiotic susceptibility tests such as modified Hodge test to confirm the carbapenem-resistant results.


Sujata Lall , Vivek Bhat, Sanjay Biswas, Navin Khattry ,
Volume 18, Issue 4 (7-2024)
Abstract

Background: Tigecycline susceptibility testing and reporting remain enigmatic due to the lack of established guidelines. Disc diffusion, as a method of performing susceptibility testing, is more widely accepted worldwide due to its ease of use. Limited published literature is available from India on the utility of this method, especially in a cancer care setting. Hence, this study was conducted to evaluate the performance characteristics of disc diffusion by comparing its results with those of the VITEK-2 COMPACT, considering the latter as the standard.
Methods: Disc diffusion was performed using Kirby-Bauer’s method on Mueller-Hinton agar with a HiMedia 15 mcg TGC disc, following FDA and EUCAST breakpoints. According to CLSI criteria, disc diffusion breakpoints can be considered acceptable when categorical agreement is ≥ 90%, the very major error is ≤ 1.5%, and the major error is ≤ 3%.
Results: Using Cohen’s kappa coefficient, the kappa value was 0.328, with a p-value of <0.05. The agreement percentage observed was 60.84%. Two strains reported as resistant by VITEK-2 COMPACT were misclassified as sensitive by disc diffusion, resulting in a very major error rate of 0.76%. A major error rate of 9.5% and a minor error rate of 27.7% were noted, as 25 strains reported as susceptible were identified as resistant.
Conclusion: Since poor agreement was observed, exceeding the acceptable performance rate, the disc diffusion method was unacceptable according to CLSI criteria. There is a gap in uniformity and a lack of streamlined, harmonized TST, which might become an alarming cause for concern.

 


Page 1 from 1     

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.